Update on endocrine aspects of breast cancer: report from the 23rd San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 6-9 December 2000.

Breast Cancer Res · 2001 · PMC138682 · PMID 11305952

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Interestingly, there was a nonsignificant trend towards a longer duration of response for Faslodex (median 19.3 versus 10.5 months), and an additional 24.8 and 18.6% of patients, respectively, had stable disease for 6 months.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.